Auditi Deb Roy, PhD, MSc
About Auditi Deb Roy, PhD, MSc
Auditi Deb Roy, PhD, MSc, is the Worldwide Medical Melanoma Lead at Bristol Myers Squibb, specializing in melanoma and immuno-oncology.
Company
Auditi Deb Roy, PhD, MSc, is currently associated with Bristol Myers Squibb. She holds multiple roles within the company, including Worldwide Medical Melanoma Lead and Associate Director, International Immuno-Oncology Network Research Liaison. Her work is based in Lawrenceville, New Jersey.
Education and Expertise
Auditi Deb Roy earned her Doctor of Philosophy (PhD) in Pharmacology from the University of Illinois at Chicago, where she studied from 2008 to 2014. Prior to that, she completed her Master of Science (MSc) in Microbiology from the University of Calcutta, and her Bachelor of Science (B.Sc.) in Microbiology, also from the University of Calcutta. Her educational background has equipped her with extensive expertise in immuno-oncology and melanoma.
Career Background
Auditi Deb Roy's career encompasses a range of roles in medical science and research. She began as an intern at the Institute of Post Graduate Medical Education & Research in Kolkata, India, followed by a Postdoctoral Research Fellowship at the Feinberg School of Medicine, Northwestern University. At Women In Bio, she served as the Communication Chair for the Chicago Chapter. Her tenure at Bristol Myers Squibb spans various roles, including Medical Science Liaison and Senior Medical Science Liaison in Immuno-Oncology Diagnostics, ultimately rising to her current positions.
Achievements
Throughout her career, Auditi Deb Roy has demonstrated a proven track record of initiating and managing cross-matrix collaborations to achieve medical objectives. She has successfully built high-profile, long-term relationships with key opinion leaders and played a crucial role in the launch of drugs and diagnostics. Known for her strong communication skills, adaptability, and problem-solving abilities, she has consistently thrived on challenges, significantly contributing to her field.
Title
As the Worldwide Medical Melanoma Lead at Bristol Myers Squibb, Auditi Deb Roy leads global efforts in melanoma research and treatment. Her role involves creating and implementing strategies to advance medical objectives in melanoma, in addition to her responsibilities as Associate Director for the International Immuno-Oncology Network Research.